« Previous
Next »
Journal of Hepatology
Volume 48, Issue 5
, Pages 743-746
, May 2008
Occult hepatitis B virus in liver tissue of individuals without hepatic disease
References
- . Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely occult?. Hepatology. 2001;34:194–203
- . Occult hepatitis B. Lancet Infect Dis. 2002;2:479–486
- . Occult hepatitis B virus infection. J Hepatol. 2007;46:160–170
- . Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients. J Med Virol. 1998;54:249–255
- . Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341:22–26
- Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology. 2004;126:102–110
- Occult hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994;343:142–146
- Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Gastroenterology. 1997;113:1668–1674
- . Use of hepatitis B core antibody-positive donors for liver transplantation. Liver Transpl. 2002;8:S82–S87
- Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology. 2007;45:277–285
- Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. Eur J Haematol. 2001;67:45–50
- . Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplant. 1989;4:207–208
- . Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. Br J Haematol. 2007;136:699–712
- Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis. 2007;39:397–408
- Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood. 2003;102:1930
- Hepatitis B virus reactivation and alemtuzumab therapy. Eur J Haematol. 2005;74:254–258
- . Occult hepatitis B and infliximab-induced HBV reactivation. Inflamm Bowel Dis. 2007;13:508–509
- . Prospective investigation of transfusion transmitted infection in recipients of over 20
000 units of blood. TTI Study Group. BMJ. 2000;320:403–406 - . Occult hepatitis B virus infection: implications in transfusion. Vox Sanguinis. 2004;86:83–91
- HBsAg non-reactive HBV infection in blood donors: transmission and pathogenicity. J Med Virol. 2007;79:S32–S36
- Report of the monothermatic EASL conference on liver transplantation for viral hepatitis. J Hepatol. 2006;45:127–143
☆ The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.
PII: S0168-8278(08)00081-0
doi: 10.1016/j.jhep.2008.01.023
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 48, Issue 5
, Pages 743-746
, May 2008
